Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of a New Formulation Useful for the Osteoarthrosis Treatment (EFO)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by Nucitec.
Recruitment status was  Active, not recruiting
Study NCT00977444   Information provided by Nucitec

First Received on September 11, 2009.   Last Updated on January 19, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Osteoarthritis
Additional conditions recognized in this trial
Joint Diseases
More general conditions related to this trial
Arthritis
Musculoskeletal Diseases
Rheumatic Diseases
Interventions listed in this trial
kondrium
kondrium f
Additional drug interventions recognized in this trial
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antiemetics
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Autonomic Agents
Central Nervous System Agents
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Neuroprotective Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Nucitec
National Council of Science and Technology, Mexico


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services